Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Vulvar Cancer
Interventions
DRUG

imiquimod

The patient will be seen in clinic every six weeks during treatment for examination. Imiquimod cream is to be applied 3 times per week for 12 weeks.

PROCEDURE

biopsy

Punch biopsy and photography will be performed at the baseline and 12 week time points.

PROCEDURE

therapeutic conventional surgery

If the lesion is still present after 12 weeks of therapy, the treating physician will recommend excision of the lesion four weeks after completion of therapy (week 16).

Trial Locations (2)

10065

Memorial Sloan Kettering Cancer Center, New York

43210-1240

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Ohio State University

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00504023 - Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva | Biotech Hunter | Biotech Hunter